Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
出版年份 2015 全文链接
标题
Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
作者
关键词
-
出版物
ANNALS OF MEDICINE
Volume 47, Issue 5, Pages 359-369
出版商
Informa UK Limited
发表日期
2015-07-09
DOI
10.3109/07853890.2015.1043140
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Host effects contributing to cancer therapy resistance
- (2015) Ofrat Beyar Katz et al. DRUG RESISTANCE UPDATES
- Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
- (2015) Steven J Edwards et al. HEALTH TECHNOLOGY ASSESSMENT
- Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
- (2015) Marina Bagnoli et al. Oncotarget
- Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance
- (2015) Eran E. Bram et al. NEOPLASIA
- Epigenetics of cancer stem cells: Pathways and therapeutics
- (2014) Samriddhi Shukla et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
- (2014) R M Glasspool et al. BRITISH JOURNAL OF CANCER
- Epigenetic Targeting of Ovarian Cancer Stem Cells
- (2014) Yinu Wang et al. CANCER RESEARCH
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer
- (2014) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Deregulation of miR-128 in Ovarian Cancer Promotes Cisplatin Resistance
- (2014) Bing Li et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
- (2014) Brendan Ffrench et al. Molecular Cancer
- Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
- (2014) Hariharan Easwaran et al. MOLECULAR CELL
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNA 130b enhances drug resistance in human ovarian cancer cells
- (2014) Can Zong et al. TUMOR BIOLOGY
- Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
- (2014) Deborah J. Marsh et al. Frontiers in Oncology
- Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
- (2013) X. Zhang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients
- (2013) J. M. Flanagan et al. ANNALS OF ONCOLOGY
- MiR-200c and HuR in ovarian cancer
- (2013) Silvia Prislei et al. BMC CANCER
- MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples
- (2013) Xiao Li et al. BMC CANCER
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- Review of processing and analysis methods for DNA methylation array data
- (2013) C S Wilhelm-Benartzi et al. BRITISH JOURNAL OF CANCER
- Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
- (2013) Elena Lum et al. GYNECOLOGIC ONCOLOGY
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
- (2013) Yu-mei Rao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells
- (2013) Mourad W. Ali et al. PLoS One
- A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
- (2013) A. Vecchione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
- (2013) J Cai et al. Oncogenesis
- The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer
- (2012) H M Coley et al. BRITISH JOURNAL OF CANCER
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Basic concepts of epigenetics
- (2012) Elizabeth A. Mazzio et al. Epigenetics
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study
- (2012) Don S. Dizon et al. GYNECOLOGIC ONCOLOGY
- Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
- (2012) Don S. Dizon et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
- (2012) Ning Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
- (2012) D. M. Cittelly et al. MOLECULAR CANCER THERAPEUTICS
- Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility
- (2012) D. Ziliak et al. MOLECULAR CANCER THERAPEUTICS
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells
- (2012) N Chapman-Rothe et al. ONCOGENE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies
- (2011) Julie Bauman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer
- (2011) N. Syed et al. CANCER RESEARCH
- Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
- (2011) W. Dai et al. CLINICAL CANCER RESEARCH
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
- (2011) Chun Yang et al. GYNECOLOGIC ONCOLOGY
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
- (2011) Bogdan Mateescu et al. NATURE MEDICINE
- Epigenome-wide association studies for common human diseases
- (2011) Vardhman K. Rakyan et al. NATURE REVIEWS GENETICS
- Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
- (2011) Wei Yu et al. PLoS One
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
- (2010) Siqing Fu et al. CANCER
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
- (2010) Sha Hu et al. CANCER BIOLOGY & THERAPY
- Structure and Function of Mammalian DNA Methyltransferases
- (2010) Renata Zofia Jurkowska et al. CHEMBIOCHEM
- Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
- (2010) Helen J. Mackay et al. EUROPEAN JOURNAL OF CANCER
- Dynamic changes in the human methylome during differentiation
- (2010) L. Laurent et al. GENOME RESEARCH
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Replication timing-related and gene body-specific methylation of active human genes
- (2010) Dvir Aran et al. HUMAN MOLECULAR GENETICS
- HERV-K Hypomethylation in Ovarian Clear Cell Carcinoma Is Associated With a Poor Prognosis and Platinum Resistance
- (2010) Kanokwan Iramaneerat et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids
- (2010) Anupam Paliwal et al. METHODS
- Conserved role of intragenic DNA methylation in regulating alternative promoters
- (2010) Alika K. Maunakea et al. NATURE
- Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
- (2010) Constanze Zeller et al. Therapeutic Advances in Medical Oncology
- Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
- (2009) Meng Li et al. BMC Medical Genomics
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
- (2009) Parvesh Chaudhry et al. CANCER INVESTIGATION
- DNA methylation and methyl-CpG binding proteins: developmental requirements and function
- (2009) Ozren Bogdanović et al. CHROMOSOMA
- The promises and pitfalls of epigenetic therapies in solid tumours
- (2009) Janet S. Graham et al. EUROPEAN JOURNAL OF CANCER
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
- (2009) Linda J. Nicholson et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
- (2009) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- Rethinking how DNA methylation patterns are maintained
- (2009) Peter A. Jones et al. NATURE REVIEWS GENETICS
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now